My point is also that rightly or wrongly, Trump responds differently based on who asks the question. If someone from the New York Times asks about Lerinlimab, it will get a different response than if someone from Fox News asks about it. Again I’m not passing judgment on that dynamic, but I think we can all agree that it is reality.

And here is the question:

“ mr. President, is it true that there is an American company that is allowing critically ill patients to recover, get out of the ICU and off of ventilators with no side effects - and is also showing promise in keeping mild and moderate patients from progressing”?

He wants to beat this virus, and ideally he wants an American company to do it. That would be the bombshell question for us.